Article ; Online: Nitrated fatty acid, 10-nitrooleate protects against hyperoxia-induced acute lung injury in mice.
International immunopharmacology
2022 Volume 109, Page(s) 108838
Abstract: The antioxidant and anti-inflammatory effects of electrophilic nitrated fatty acid (NFA); 10-nitrooleate, have been reported. The present study investigated whether 10-nitrooleate has a protective role against hyperoxic-induced acute lung injury (HALI). ... ...
Abstract | The antioxidant and anti-inflammatory effects of electrophilic nitrated fatty acid (NFA); 10-nitrooleate, have been reported. The present study investigated whether 10-nitrooleate has a protective role against hyperoxic-induced acute lung injury (HALI). Using a C57BL/6 mice model of HALI, we investigated the protective effect of 10-nitrooleate. C57BL/6 mice were administered with NFA intratracheally, exposed to hyperoxia for 48 h to induce HALI, and kept at room air for 24 h. Bronchoalveolar lavage (BAL) fluid and lung samples were collected after 24 h of post hyperoxia to analyze markers associated with HALI. Intratracheal (IT) and intraperitoneal (IP) administration of NFA notably attenuated hyperoxia-induced infiltration of inflammatory cells, alveolar-capillary leakage, upregulation of proinflammatory cytokine levels (IL-6 and TNFα) into the BAL fluid, and resolution of inflammation in the lung. Western blot analyses showed that 10-nitrooleate reduced the expression of the inflammatory transcription factor NFκB p65 subunit and increased antioxidant proteins HO-1 and NQO1 expression in the lung tissues compared to vehicle-treated animals. Moreover, 10-nitrooleate reversed the hyperoxia-induced expression of mitophagy-associated markers (PINK1 and p62/SQSTM1), thereby protecting the HALI/ acute respiratory distress syndrome (ARDS). IT and IP delivery of 10-nitrooleate reduces hyperoxia-induced ALI/ARDS by regulating the antioxidant pathways and restoring the mitochondrial homeostasis by regulating mitophagy. It is suggested that NFAs can be further evaluated as supplementary therapy for critically ill patients like COVID-19/ARDS. |
---|---|
MeSH term(s) | Acute Lung Injury/chemically induced ; Animals ; Antioxidants/metabolism ; Antioxidants/therapeutic use ; COVID-19 ; Fatty Acids/metabolism ; Humans ; Hyperoxia/complications ; Hyperoxia/metabolism ; Lung/metabolism ; Lung Injury/metabolism ; Mice ; Mice, Inbred C57BL ; Nitrates/adverse effects ; Nitrates/metabolism ; Respiratory Distress Syndrome |
Chemical Substances | Antioxidants ; Fatty Acids ; Nitrates |
Language | English |
Publishing date | 2022-05-11 |
Publishing country | Netherlands |
Document type | Journal Article |
ZDB-ID | 2043785-7 |
ISSN | 1878-1705 ; 1567-5769 |
ISSN (online) | 1878-1705 |
ISSN | 1567-5769 |
DOI | 10.1016/j.intimp.2022.108838 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5408: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.